Veterinary Medicine Information website

CUBOLAC ενέσιμο εναιώρημα για βοοειδή, πρόβατα και αίγες

Authorised
  • Clostridium chauvoei, toxoid
  • Clostridium sordellii, toxoid
  • Clostridium novyi, type B, alpha toxoid
  • Clostridium septicum, toxoid
  • Clostridium perfringens, type D, epsilon toxoid
  • Clostridium perfringens, type C, beta toxoid
  • Clostridium perfringens, type A, alpha toxoid
Download as PDF

Product identification

Medicine name:
CUBOLAC ενέσιμο εναιώρημα για βοοειδή, πρόβατα και αίγες
Active substance:
  • Clostridium chauvoei, toxoid
  • Clostridium sordellii, toxoid
  • Clostridium novyi, type B, alpha toxoid
  • Clostridium septicum, toxoid
  • Clostridium perfringens, type D, epsilon toxoid
  • Clostridium perfringens, type C, beta toxoid
  • Clostridium perfringens, type A, alpha toxoid
Target species:
  • Goat
  • Cattle
  • Sheep
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Clostridium chauvoei, toxoid
    100.00
    Percentage protective dose
    /
    2.00
    millilitre(s)
  • Clostridium sordellii, toxoid
    100.00
    Percentage protective dose
    /
    2.00
    millilitre(s)
  • Clostridium novyi, type B, alpha toxoid
    3.50
    international unit(s)/millilitre
    /
    2.00
    millilitre(s)
  • Clostridium septicum, toxoid
    2.50
    international unit(s)/millilitre
    /
    2.00
    millilitre(s)
  • Clostridium perfringens, type D, epsilon toxoid
    5.00
    international unit(s)/millilitre
    /
    2.00
    millilitre(s)
  • Clostridium perfringens, type C, beta toxoid
    10.00
    international unit(s)/millilitre
    /
    2.00
    millilitre(s)
  • Clostridium perfringens, type A, alpha toxoid
    0.30
    international unit(s)/millilitre
    /
    2.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Goat
      • Not applicable
        no withdrawal period
    • Cattle
      • Not applicable
        no withdrawal period
    • Sheep
      • Not applicable
        no withdrawal period
  • Subcutaneous use
    • Goat
      • Not applicable
        no withdrawal period
    • Cattle
      • Not applicable
        no withdrawal period
    • Sheep
      • Not applicable
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI02AB01
  • QI04AB01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Greece
Available in:
  • Greece
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Complete application (stand-alone)
Marketing authorisation holder:
  • CZ Vaccines S.A.U.
Marketing authorisation date:
Manufacturing sites for batch release:
  • CZ Vaccines S.A.U.
Responsible authority:
  • National Organization For Medicines
Authorisation number:
  • 75236/10-08-2021/K-0228101
Date of authorisation status change: